only a few hundred people in the United States the disease, known as homozygous familial hypercholesterolemia, or HoFH and The treatment may generate $50 million in 2016 for Isis, according to the average of four analysts’ estimates compiled by Bloomberg.
THE INVESTORS NEVER GOING TO SEE THAT $2 BILLIONS GAIN WITH $50 per year revenue
Treatment costs $235,000 to $295,000 per year. Nice chunk of change. People with this genetic disorder will need to stay on this medication. Not many other options besides statins. I hope this drug helps a lot of people.